SHARON HILL, PA — NuvemRx recently launched Mission Control, an analytics and advisory operation designed to help community health providers manage pharmacy programs amid changes tied to the Inflation Reduction Act.
The platform combines data analysis with expert support to provide guidance on patient access, reimbursement, and 340B program performance across NuvemRx’s network of more than 800 covered entities.
The company said the initiative is intended to address new complexities stemming from Medicare Part D redesign, pricing negotiations, and shifting payer policies affecting safety-net providers.
Mission Control draws on data from more than 1.5 billion processed claims and $2.6 billion in cumulative 340B savings across the network.
“The providers we work with told us what they actually need: practical insights they can’t get anywhere else,” said Scott Seidelmann, chief executive officer of NuvemRx.
To lead the initiative, NuvemRx appointed Charles Hirner as senior vice president. Hirner has more than 20 years of experience in pharmacy operations and previously held leadership roles at Omnicell, PSG, and OptumRx.
“The regulatory landscape is shifting faster than most providers can track,” Hirner said, citing pricing changes, evolving payer policies, and manufacturer restrictions.
Mission Control supports clients across NuvemRx’s service lines, including third-party administration, pharmacy management, and referral programs, and provides data-driven insights through dedicated account support.
The company said the initiative is part of a broader effort to help providers adapt to regulatory changes and improve pharmacy program outcomes.
Support the local news that supports Chester County. MyChesCo delivers reliable, fact-based reporting and essential community resources—free for everyone. If you value that, click here to become a patron today.